Herantis Pharma applies for delisting regarding the secondary listing of its shares from Nasdaq First North Growth Market Sweden
Herantis Pharma Plc, Company release, 1 December 2022 at 11:30 EET Herantis Pharma will be traded solely on Nasdaq First North Growth Market Finland under the trading code: HRTIS (ISIN code: FI4000087861) Herantis Pharma Plc ("Herantis") developing disease modifying therapies for Parkinson’s disease, has applied for delisting of its shares from Nasdaq First North Growth Market Sweden (“Nasdaq FN GM Sweden”). When adopting the decision on applying for the delisting, the Board of Directors considered the development of trading since the company listed its shares on Nasdaq FN GM